Post-Vaccination Coronavirus Disease 2019: A Case-Control Study and Genomic Analysis of 119 Breakthrough Infections in Partially Vaccinated Individuals

Abstract

Background Post-vaccination infections challenge the control of the COVID-19 pandemic. Methods We matched 119 cases of post-vaccination SARS-CoV-2 infection with BNT162b2 mRNA, or ChAdOx1 nCOV-19, to 476 unvaccinated patients with COVID-19 (Sept 2020-March 2021), according to age and sex. Differences in 60-day all-cause mortality, hospital admission, and hospital length of stay were evaluated. Phylogenetic, single nucleotide polymorphism (SNP) and minority variant allele (MVA) full genome sequencing analysis was performed. Results 116/119 cases developed COVID-19 post first vaccination dose (median 14 days, IQR 9 – 24 days). Overall, 13/119 (10∙9%) cases and 158/476 (33∙2%) controls died (p<0.001), corresponding to 4∙5 number needed to treat (NNT). Multivariably, vaccination was associated with 69∙3% (95%CI 45∙8 – 82∙6) relative risk (RR) reduction in mortality. Similar results were seen in subgroup analysis for patients with infection onset ≥14 days after first vaccination (RR reduction 65∙1%, 95%CI 27∙2 – 83∙2, NNT 4∙5), and across vaccine subgroups (BNT162b2: RR reduction 66%, 95%CI 34∙9 – 82∙2, NNT 4∙7, ChAdOx1: RR reduction 78∙4%, 95%CI 30∙4 – 93∙3, NNT 4∙1). Hospital admissions (OR 0∙80, 95%CI 0∙51 – 1∙28), and length of stay (-1∙89 days, 95%CI -4∙57 – 0∙78) were lower for cases, while Ct values were higher (30∙8 versus 28∙8, p = 0.053). B.1.1.7 was the predominant lineage in cases (100/108, 92.6%) and controls (341/446, 76.5%). Genomic analysis identified one post-vaccination case harboring the E484K vaccine escape mutation (B.1.525 lineage). Conclusions Previous vaccination reduces mortality when B.1.1.7 is the predominant lineage. No significant lineage-specific genomic changes during phylogenetic, SNP and MVA analysis were detected.

The Role of Risk Perception in Students’ COVID-19 Vaccine Uptake: A Longitudinal Study

“…This implies that COVID-19 vaccine acceptance and uptake among young adults is related to the perceived severity of COVID-19 rather than the perceived chance of getting it. One reason for this might be that while COVID-19 vaccination reduces the severity of symptoms and number of deaths [49], it does not automatically prevent infection because immunity may wane over time [50]. Incidence of COVID-19 among young adults is high, while the burden of disease is relatively low [51].…”

“…Moreover, while the mortality of young adults with COVID-19 is low [51], more and more cases in which young adults suffer from severe and long-term symptoms are found [53]. Vaccination will help to lower the severity of the symptoms and decrease mortality [49].…”

Virological and Serological Characterisation of SARS-CoV-2 Infections Diagnosed After mRNA BNT162b2 Vaccination Between December 2020 and March 2021

“…The differences with our results may be due to different patterns of variants circulation, as, for example, circulation of Beta VOC was very tiny in our territory. According to other studies, the analysis of the Spike mutations in each lineage, broken down by Groups 1, 2, and 3, indicated that there is no selection for the enrichment of any particular mutation in fully vaccinated individuals (Group 3) as compared to individuals with incomplete vaccination (Groups 1 and 2) ( 36 ).…”

Hospital length of stay in a mixed Omicron and Delta epidemic in New South Wales, Australia

“…It has been suggested that vaccination may result in a reduced length of stay [25], though evidence in this regard is limited. The reduced length of stay observed between the two epidemic periods could be a result of the changes in vaccination coverage.…”